Dirk Sibbing
319 works · 49,759 citations · h-index 67
Top works
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
- Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
- Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
- Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel
- European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
- Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
- Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention